Accordingly, loss-of-function mutations in PTEN can enhance insulin signaling in different organs, leading to protection against insulin resistance, a critical pathogenic process in NAFLD and T2DM (41, 42, 43, 44). Here, PTEN is linked to metabolic dysfunction-associated steatotic liver disease.